Safety of Newborn infants Threatened by Rx antidepressants during pregnancy
"During a hastily called press conference yesterday,” the FDA announced that it is considering ADDITIONAL warnings on the labels of SSRI drugs—Prozac, Paxil, Zoloft, et al.
"During a hastily called press conference yesterday,” the FDA announced that it is considering ADDITIONAL warnings on the labels of SSRI drugs—Prozac, Paxil, Zoloft, et al.
It is astonishing how untrustworthy loosely given advice about the safety of SSRI antidepressants by medical professionals and academic institutions.
A critical examination of meta-analysis studies by John H. Noble, Jr, Ph.D, AHRP Treasurer
Authors of the American College of Neuropsychopharmacology Task Force on SSRIs and Suicidal Behavior in Youth: their known ties to the pharmaceutical industry
Even Dr. Robet Temple, FDA Medical Policy Director of the Center for Drug Evaluation & Research dismisses the claimed finidings of a flawed, but highly trumpeted recent SSRI study published in the American Journal of Psychiatry. The study was sponsored by the National Institute of Mental Health.
Two studies purporting to report “new encouraging” findings about the efficacy and safety of antidepressants—as tested in the “real world”—were published on Sunday by The American Journal of Psychiatry with an accompanying editorial by Dr. Thomas Insel, director of these studies’ funding agency, the National Institute of Mental Health.
"Serotonin and depression: A disconnect between the advertisements and the scientific literature."
"Some 19 million people in the U.S. suffer from depression in any given year. For many, SSRIs help little, if at all. To do better, we have to get the science right." Sharon Begley, Wall Street Journal
The Columbia lecture was originally scheduled as a debate between David Healy, MD and James Coyne, PhD. The debate did not take place, and Dr. Coyne subsequently lectured in Rutgers the following week. The lecture covered the main points Dr. Coyne makes in the e-mail below. Dr. Healy’s response follows….
AMERICA’S OVERMEDICATED CHILDREN By Vera Sharav YOUTH and MEDICINES in June 1-3, 2005 KILEN: Consumers Institute for Medicines and Health SWEDEN “Forgotten Children” is an investigative report by Carole Keeton Strayhorn,[1] the Texas Comptroller (2004) who uncovered evidence that 60% of children in the Texas foster care system are being…
“Forgotten Children” is an investigative report by Carole Keeton Strayhorn,[1] the Texas Comptroller (2004) who uncovered evidence that 60% of children in the Texas foster care system are being drugged with powerful psychotropic drugs, most of which have not been tested in or approved for use by children. The Food and Drug Administration (FDA) acknowledges that many of these drugs have serious adverse side effects, both physical and psychological. The Comptroller said she was alarmed that in her review of a single month (November 2003), two powerful antipsychotic drugs — Risperdal and Zyprexa — made up half of the drugs prescribed to foster children in Texas. These two drugs have been approved only for adults for the treatment of psychosis – primarily schizophrenia – yet, she found that children as young as four, were receiving these powerful, mind-altering drugs.
From the Los Angeles Times THE NATION Suicide Rate Down in the Era of Prozac Numbers have declined since a 1980s peak when such drugs came into use, a study finds. A skeptic says gun laws might be the cause. By Alan Zarembo Times Staff Writer February 3, 2005 The…